Literature DB >> 1467883

Mycetoma.

A H Fahal1, M A Hassan.   

Abstract

Mycetoma is a chronic infective condition of tropical and subtropical regions. It is commoner in males, especially those in their third or fourth decade who work on the land. The clinical triad of subcutaneous nodule, sinuses and discharge usually leads to diagnosis; the disease is commonly painless. Treatment is by extensive surgical excision of affected areas and may include limb amputation. Recurrence is common, rates ranging from 20 to 90 per cent. Medical treatment may be used on its own or as an adjunct to surgery. Although such therapy may cure over half of those with actinomycetoma (caused by bacteria, mainly aerobic actinomycetes), those affected by eumycetoma (caused by fungi) have a poorer prognosis and may require many years of drug therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1467883     DOI: 10.1002/bjs.1800791107

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  42 in total

Review 1.  Madura foot: two case reports, review of the literature, and new developments with clinical correlation.

Authors:  Eric A White; Dakshesh B Patel; Deborah M Forrester; Christopher J Gottsegen; Emily O'Rourke; Paul Holtom; Timothy Charlton; George R Matcuk
Journal:  Skeletal Radiol       Date:  2013-10-23       Impact factor: 2.199

2.  Unexpected high prevalence of secondary bacterial infection in patients with mycetoma.

Authors:  A O Ahmed; E S Abugroun
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

3.  Negative pressure wound therapy and skin graft in madura foot treatment.

Authors:  Ali Murat Kalender; Halit Baykan; Fuat Ozkan; Harun Cıralık; Perihan Oztürk; Mustafa Gül; Hasan Uçmak
Journal:  Balkan Med J       Date:  2012-06-01       Impact factor: 2.021

4.  Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.

Authors:  Wendy W J van de Sande; Ad Luijendijk; Abdalla O A Ahmed; Irma A J M Bakker-Woudenberg; Alex van Belkum
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  Pleurostomophora ochracea, a novel agent of human eumycetoma with yellow grains.

Authors:  Najwa A Mhmoud; Sarah Abdalla Ahmed; Ahmed H Fahal; G Sybren de Hoog; A H G Gerrits van den Ende; Wendy W J van de Sande
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

6.  Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis.

Authors:  A O Ahmed; M M Mukhtar; M Kools-Sijmons; A H Fahal; S de Hoog; B G van den Ende; E E Zijlstra; H Verbrugh; E S Abugroun; A M Elhassan; A van Belkum
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 7.  Actinomycetoma-the welsh regimen in a rural Indian scenario.

Authors:  Saumya Mathews; Raviraj Jadhav; Ali Reza; Tanweer Karim
Journal:  Indian J Surg       Date:  2012-05-01       Impact factor: 0.656

Review 8.  Mycetomas in Iran: a review article.

Authors:  Ali Zarei Mahmoudabadi; Majid Zarrin
Journal:  Mycopathologia       Date:  2007-10-06       Impact factor: 2.574

9.  Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal.

Authors:  Abdalla Ahmed; Wendy van de Sande; Henri Verbrugh; Ahmed Fahal; Alex van Belkum
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Phylogenetic findings suggest possible new habitat and routes of infection of human eumyctoma.

Authors:  G Sybren de Hoog; Sarah A Ahmed; Mohammad J Najafzadeh; Deanna A Sutton; Maryam Saradeghi Keisari; Ahmed H Fahal; Ursala Eberhardt; Gerard J Verkleij; Lian Xin; Benjamin Stielow; Wendy W J van de Sande
Journal:  PLoS Negl Trop Dis       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.